Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Comparison of efficiency and preference of metal and plastic spacers in preschool children.

Amirav I, Tiosano T, Chamny S, Chirurg S, Oren S, Grossman Z, Kahan E, Newhouse MT, Mansour Y; IPROS Network.

Ann Allergy Asthma Immunol. 2004 Sep;93(3):249-52.

PMID:
15478384
3.

Redesigned face mask improves "real life" aerosol delivery for Nebuchamber.

Amirav I, Mansour Y, Mandelberg A, Bar-Ilan I, Newhouse MT.

Pediatr Pulmonol. 2004 Feb;37(2):172-7.

PMID:
14730663
4.

In vivo comparison of the relative systemic bioavailability of fluticasone propionate from three anti-static spacers and a metered dose inhaler.

Nair A, Menzies D, Hopkinson P, McFarlane L, Lipworth BJ.

Br J Clin Pharmacol. 2009 Feb;67(2):191-8. doi: 10.1111/j.1365-2125.2008.03350.x. Epub 2009 Feb 9.

5.

Safety of inhaled corticosteroids delivered by plastic and metal spacers.

Amirav I, Mansour Y, Tiosano T, Chamny S, Chirurg S, Oren S, Grossman Z, Kahana L, Kahan E, Newhouse MT; Ipros Network.

Arch Dis Child. 2003 Jun;88(6):527-8.

6.

Albuterol aerosol delivered via metered-dose inhaler to intubated pediatric models of 3 ages, with 4 spacer designs.

Mandhane P, Zuberbuhler P, Lange CF, Finlay WH.

Respir Care. 2003 Oct;48(10):948-55.

7.

Adrenal suppression in asthmatic children receiving low-dose inhaled budesonide: comparison between dry powder inhaler and pressurized metered-dose inhaler attached to a spacer.

Goldberg S, Einot T, Algur N, Schwartz S, Greenberg AC, Picard E, Virgilis D, Kerem E.

Ann Allergy Asthma Immunol. 2002 Dec;89(6):566-71.

PMID:
12487221
8.

Aerosol delivery to young children by pMDI-spacer: is facemask design important?

Esposito-Festen J, Ates B, van Vliet F, Hop W, Tiddens H.

Pediatr Allergy Immunol. 2005 Jun;16(4):348-53.

PMID:
15943599
9.

Variability of aerosol delivery via spacer devices in young asthmatic children in daily life.

Janssens HM, Devadason SG, Hop WC, LeSouëf PN, De Jongste JC, Tiddens HA.

Eur Respir J. 1999 Apr;13(4):787-91.

10.

In vitro and clinical characterization of the valved holding chamber AeroChamber Plus® Flow-Vu® for administrating tiotropium Respimat® in 1-5-year-old children with persistent asthmatic symptoms.

Wachtel H, Nagel M, Engel M, El Azzi G, Sharma A, Suggett J.

Respir Med. 2018 Apr;137:181-190. doi: 10.1016/j.rmed.2018.03.010. Epub 2018 Mar 7.

11.
12.

Early intervention of recent onset mild persistent asthma in children aged under 11 yrs: the Steroid Treatment As Regular Therapy in early asthma (START) trial.

Chen YZ, Busse WW, Pedersen S, Tan W, Lamm CJ, O'Byrne PM.

Pediatr Allergy Immunol. 2006 May;17 Suppl 17:7-13.

PMID:
16573703
14.

Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.

Szefler SJ, Baker JW, Uryniak T, Goldman M, Silkoff PE.

J Allergy Clin Immunol. 2007 Nov;120(5):1043-50.

PMID:
17983871
16.

Randomised controlled study of clinical efficacy of spacer therapy in asthma with regard to electrostatic charge.

Dompeling E, Oudesluys-Murphy AM, Janssens HM, Hop W, Brinkman JG, Sukhai RN, de Jongste JC.

Arch Dis Child. 2001 Feb;84(2):178-82.

17.
18.
19.

Pressurised metered-dose inhalers (MDIs) versus dry powder inhalers devices (DPIs) to rapid-acting inhaled b2-agonists for asthma in children.

Negro Alvarez JM, Miralles López JC, Félix Toledo R, Pagán Alemán JA, García Sellés FJ, López Sánchez JD, Hernández García J.

Allergol Immunopathol (Madr). 2002 Jul-Aug;30(4):245-9. Review.

PMID:
12199971
20.

A new small volume holding chamber for asthmatic children: comparison with Babyhaler spacer.

Voeurng V, Andrieu V, Bun H, Reynier JP, Dubus JC.

Pediatr Allergy Immunol. 2006 Dec;17(8):629-34.

PMID:
17121592

Supplemental Content

Support Center